ArticleFrontiers in neuroscience2026
Dopaminergic manipulation modulates frequency-specific EEG connectivity patterns: evidence from a single dose drug challenge study.
Article in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Dysregulation in resting-state connectivity in electroencephalogram (EEG) and dysregulation in the dopamine system have both been repeatedly observed in patients with psychotic disorders. It is unclear whether dopaminergic drugs, used to treat psychotic disorders, induce treatment-relevant connectivity changes in the brain. Investigating the effects of dopaminergic drugs in healthy participants could provide crucial insights into how dopaminergic modulation directly influences resting-state connectivity. Methods: In a randomized controlled crossover study including 58 healthy participants, we examined the effects of L-dopa (dopamine pre-cursor), haloperidol (dopamine D2 antagonist), and placebo on frequency-specific connectivity patterns (intrinsic coupling modes; ICMs). Source-space connectivity between brain regions was calculated for phase ICMs via multivariate interaction measure, and for envelope ICMs via orthogonalized power correlation. Results: Phase ICMs showed a significant linear increase (from L-dopa to placebo to haloperidol) in the delta frequency, and a significant linear decrease in the low-beta frequency. Gamma phase ICMs were significantly reduced in both drug conditions compared to placebo. Orthogonalized power correlation showed a significant linear decrease (from L-dopa to placebo to haloperidol), in the alpha and low-beta frequency. Discussion: Our findings in the gamma band support the long-standing hypothesis that dopaminergic action on large-scale neural networks follows an inverted U-shaped curve. The linear pattern of our findings in the delta, alpha, and low-beta frequency bands reflect possible relevant effects for psychotic symptoms. However, our findings are difficult to relate to existing findings in patients. Our results highlight the need for further prospective studies in patients to better understand the relationship between dopaminergic effects and ICMs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.